Stefania Zona

1.4k total citations
17 papers, 1.1k citations indexed

About

Stefania Zona is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Stefania Zona has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Stefania Zona's work include FOXO transcription factor regulation (14 papers), PARP inhibition in cancer therapy (6 papers) and Cell death mechanisms and regulation (3 papers). Stefania Zona is often cited by papers focused on FOXO transcription factor regulation (14 papers), PARP inhibition in cancer therapy (6 papers) and Cell death mechanisms and regulation (3 papers). Stefania Zona collaborates with scholars based in United Kingdom, Hong Kong and Spain. Stefania Zona's co-authors include Eric W.‐F. Lam, Gabriela Nestal de Moraes, Laura Bella, Matthew J. Burton, Ana Gomes, Pasarat Khongkow, Mesayamas Kongsema, US Khoo, René H. Medema and Raimundo Freire and has published in prestigious journals such as Oncogene, Seminars in Cancer Biology and Breast Cancer Research and Treatment.

In The Last Decade

Stefania Zona

17 papers receiving 1.1k citations

Peers

Stefania Zona

ONCOL

PFM

Baohua Sun United States

Helena M. Yoder United States

Gerald Chu United States

Gerald Schmid Austria

Yugang Wen China

Lydia Kriegl Germany

Hien Dang United States

So Mee Kwon South Korea

Terje Ahlquist Norway

Baohua Sun United States

Stefania Zona

893 ×1.0

268 ×0.9

ONCOL

117 ×0.6

52 ×0.3

83 ×0.6

PFM

Citations per year, relative to Stefania Zona Stefania Zona (= 1×) peers Baohua Sun

Countries citing papers authored by Stefania Zona

Since Specialization

Citations

This map shows the geographic impact of Stefania Zona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Zona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Zona more than expected).

Fields of papers citing papers by Stefania Zona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Zona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Zona. The network helps show where Stefania Zona may publish in the future.

Co-authorship network of co-authors of Stefania Zona

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Zona. A scholar is included among the top collaborators of Stefania Zona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Zona. Stefania Zona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tsoi, Ho, Chun Gong, Stefania Zona, et al.. (2020). A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2. Cancers. 12(3). 533–533. 9 indexed citations

Alasiri, Glowi, Yannasittha Jiramongkol, Stefania Zona, et al.. (2019). Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells. Oncogene. 38(36). 6382–6398. 34 indexed citations

Mahmud, Zimam, Ana Gomes, Hee Jin Lee, et al.. (2019). EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer. Cancers. 11(8). 1067–1067. 35 indexed citations

Natoli, Marina, Lynsey M. Whilding, Ana C. Parente‐Pereira, et al.. (2018). Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer. Cancer Immunology Immunotherapy. 67(11). 1753–1765. 29 indexed citations

Moraes, Gabriela Nestal de, Zongling Ji, Shang J. Yao, et al.. (2018). SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells. Oncogenesis. 7(3). 29–29. 24 indexed citations

Alasiri, Glowi, et al.. (2017). ER stress and cancer: The FOXO forkhead transcription factor link. Molecular and Cellular Endocrinology. 462(Pt B). 67–81. 42 indexed citations

Yang, Na, Stefania Zona, Min Yan, et al.. (2017). FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells. Oncogene. 36(24). 3428–3440. 90 indexed citations

Kongsema, Mesayamas, Stefania Zona, Ellen P.S. Man, et al.. (2016). RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment. Oncogenesis. 5(8). e252–e252. 31 indexed citations

Moraes, Gabriela Nestal de, Laura Bella, Stefania Zona, Matthew J. Burton, & Eric W.‐F. Lam. (2016). Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance. Current Drug Targets. 17(2). 164–177. 59 indexed citations

10.

Ghaem‐Maghami, Sadaf, Roberta Bortolozzi, Stefania Zona, et al.. (2015). FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL. Molecular Cancer Research. 13(12). 1578–1590. 27 indexed citations

11.

Kongsema, Mesayamas, Stefania Zona, Chun Gong, et al.. (2015). OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance. Oncogene. 35(11). 1433–1444. 122 indexed citations

12.

Moraes, Gabriela Nestal de, Marcela Cristina Robaina, Pasarat Khongkow, et al.. (2015). FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance. Cellular Signalling. 27(12). 2496–2505. 98 indexed citations

13.

Bella, Laura, Stefania Zona, Gabriela Nestal de Moraes, & Eric W.‐F. Lam. (2014). FOXM1: A key oncofoetal transcription factor in health and disease. Seminars in Cancer Biology. 29. 32–39. 124 indexed citations

14.

Zona, Stefania, Laura Bella, Matthew J. Burton, Gabriela Nestal de Moraes, & Eric W.‐F. Lam. (2014). FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1839(11). 1316–1322. 168 indexed citations

15.

Khongkow, Pasarat, Mattaka Khongkow, Chun Gong, et al.. (2013). FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene. 33(32). 4144–4155. 107 indexed citations

16.

Myatt, Stephen S., Mesayamas Kongsema, Douglas J. Kelly, et al.. (2013). SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene. 33(34). 4316–4329. 85 indexed citations

17.

Blackburn, Edith, et al.. (2011). A monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell lines. Breast Cancer Research and Treatment. 134(1). 53–59. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact